Cagri 2T Blend (20mg)

Cagri 2T Blend (20mg) typically refers to an unregulated, compounded combination of Cagrilintide and another peptide (often Semaglutide or Tirzepatide) sold for research purposes. It is not an FDA-approved medication and carries serious safety and regulatory risks.